true
Icon to close the modal
Support
Sales
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Submit a form online
Go next / move forward Icon
Modal Close Icon

Capability:

Product Line:

Icon to close thank you modal
Thank you for contacting our sales team!
A sales representive will get in touch with you shortly.
Customer Service
Phone Icon
1.844.8.BD.LIFE (1.844.823.5433)
Fax Icon
1.800.847.2220
Products

Facilimix™ Compounding Solution

Helping you take the strain out of the hospital pharmacy

Contact Us
Carousel Image
HDS_Facilimix-compounding-device
HDS_Facilimix-cartridge
Loading
Overview

The risk of developing repetitive strain injury (RSI) is high for hospital pharmacy technicians and nurses.1,2 Risk factors for RSI include repetitive motions, exertion of high or prolonged muscular forces, fast-paced work environment with insufficient rest or recovery time during work or between shifts, and can lead to a decrease in productivity, medical treatment, time off or even disability.3

Facilimix™ is designed to help reduce RSI due to repetition of motions needing to exert some pressure or forces (mixing viscous drugs / filling elastomeric pumps) without compromising patient safety or efficiency of the compounding process.

true

Features and Benefits

Facilimix™ Compounding Device is designed to eliminate syringe push/pull motions.


Intuitive to use, as the device mimics syringe motion, it enables to withdraw and inject compound with one finger.

The Facilimix™ Cartridge is a dedicated patented* double seal syringe designed for use with the Facilimix™ Compounding Device.


Compatible with oncology drugs including paclitaxel4,5 the standard luer lock cartridge has a double seal to increase accuracy and avoid leakage.

Related Videos

Facilimix™ in use with BD Texium™

Facilimix™ in use with BD PhaSeal™

Facilimix™ in use with BD PhaSeal™ Optima

Resources
false
true

References

Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

*patent number: US 2013/0199668 A1

References

  1. F. Reisz, AC. Gairard-Dory, K. Fonmartin, J. Bourbon, B. Gourieux. Prévention des troubles musculo squelettiques en pharmacotechnie. Groupe d’évalutation de recherche sur la protection en atmosphère contrôlée (GERPAC). GERPAC . Accessed on May 6, 2018.

  2. The National Institute for Occupational Safety and Health (NIOSH) Safe patient handling and mobility (SPHM). Safe Patient Handling and Mobility (SPHM) | NIOSH | CDC . Accessed June, 2019.

  3. Nancy N. Byl, Mary F. Barbe, Carolyn Byl Dolan, Grant Glass. Repetitive Stress Pathology: Soft Tissue in Pathology and Intervention in Musculoskeletal Rehabilitation. Second Edition 2016, Pages 938-1004.

  4. Dr. Federico Reverberi. Paclitaxel stability in physiologic solution after contact with medical device. August 2016

  5. J. Vignerona et al. SFPO and ESOP recommendations for the practical stability of anticancer drugs: An update. Annales Pharmaceutiques Françaises (2013) 71, 376—389

BD-22023

true